Michael A. Alrutz
General Counsel, SYNAGEVA BIOPHARMA CORP.
Companies
- Chimerix (United States)General counsel Feb 2, 2024 to now1
- Chimerix (United States)Principal Executive Officer Feb 7, 2019 to Jan 19, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Chimerix (United States)0 shares3Apr 21, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 21, 2025Returned to company 216,689 shares at $8.55 of Chimerix (United States)3
- Feb 13, 2025Sold 1,600 shares at $4.52 of Chimerix (United States)4
- Jan 7, 2025Granted 41,667 shares of Chimerix (United States)5
- Feb 1, 2024Granted 21,875 shares of Chimerix (United States)6
- Jan 17, 2023Granted 21,450 shares of Chimerix (United States)7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 14, 2025
- 5SEC EDGARForm 4 filed Jan 10, 2025
- 6SEC EDGARForm 4 filed Feb 2, 2024
- 7SEC EDGARForm 4 filed Jan 19, 2023